Nancy A Costello

Nancy A. Costello serves as a Contract Support Specialist at the Drug Enforcement Administration Headquarters (15DDHQ), providing critical procurement support for mission-critical acquisitions that advance federal drug enforcement capabilities. She plays a pivotal role in facilitating the acquisition of advanced surveillance, secure communications, and forensic analytical technologies essential to operational intelligence and lawful intercept operations. Her work spans the full lifecycle of contract actions, from requirements validation and market research to solicitation drafting and vendor coordination, ensuring compliance with federal acquisition regulations while aligning purchases with DEA’s strategic modernization goals. Costello maintains consistent working relationships with specialized contractors including OCTASIC US INC., OBSIDIAN INTEGRATION, LLC, CAYMAN CHEMICAL CO INC, FOCUS CAMERA LLC, and SECURITY PRODUCTS INTERNATIONAL, LLC. These partnerships reflect a focus on niche vendors offering high-precision instrumentation, secure digital forensics tools, surveillance equipment, and chemical analysis services tailored to law enforcement needs. Her procurement approach emphasizes technical specificity, vendor reliability, and rapid responsiveness to evolving operational demands. Her contracting patterns show a strong preference for unrestricted competitions, with 59.5% of awards issued without set-asides, yet she actively supports small business participation through Total Small Business Set-Asides, which account for 38.1% of awards. While 8(a) and Service-Disabled Veteran-Owned Small Business set-asides are utilized sparingly, her portfolio reflects a deliberate and compliant engagement with the small business ecosystem under FAR Part 19. Costello’s primary procurement focus lies in NAICS 511210 (Software Publishers), supporting custom analytical platforms and data management systems, followed by 334511 for search and detection instrumentation, and 541519 for specialized computer services. Her domain expertise centers on acquiring cutting-edge technologies for digital evidence processing, real-time surveillance, and chemical identification—critical tools in DEA’s fight against illicit drug networks.